USFDA concludes inspection at Raleigh plant of Aurobindo Pharma’s arm

12 Apr 2025 Evaluate

The US Food and Drug Administration (USFDA) has concluded inspection at Raleigh plant at North Carolina, USA, owned by Aurolife Pharma LLC, wholly owned step-down subsidiary of Aurobindo Pharma. The inspection was completed on April 10, 2025 and at the conclusion, the USFDA issued a Form 483 with 11 observations. These observations are procedural in nature.

USFDA had conducted inspection at the plant from March 24, 2025, to April 10, 2025.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1217.85 -39.75 (-3.16%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...